암환자 우울증의 약물중재 = Evidence Based Pharmacotherapy for Depression in Patients with Cancer

다국어 초록 (Multilingual Abstract)

Objectives: A significant number of cancer patients experience depressive disorders. Numerous studies have demonstrated that depression in such patients is under-diagnosed and inadequately treated, due to various factors. One of these factors is a lack of an evidence supporting the use of antidepressants in cancer patients. The aim of this systematic review was to establish the evidence for the pharmacological treatment of depression in this population.
Methods: We searched Korean domestic and international database using the keywords“cancer”,“depression”, and“pharmacological treatment”, limiting the search to articles published between 1980 and 2008 and grading the reviewed studies’ quality according to Scottish Intercollegiate Guideline Network (SIGN) methodology.
Results: Of 283 studies searched, 28 studies were appropriate for review.
Conclusion: The evidence for the pharmacological treatment of depression as limited. However, based on available literature, it seems the newer antidepressants are better tolerated and can be continued safely, with satisfactory efficacy, in cancer patients. Further well-designed, long-term follow-up studies should be conducted.

참고문헌 (Reference)

1 김성완, "유방암 환자에서 항우울제의 사용" 대한정신약물학회 20 (20): 63-77, 2009

2 김성완, "암 환자의 우울증" 대한생물정신의학회 13 (13): 1-5, 2006

3 Pezzella G, "Treatment of depression in patients with breast cancer: a comparison between paroxetine and amitriptyline" 70 : 1-10, 2001

4 Evans DL, "Treatment of depression in cancer patients is associated with better life adaptation: a pilot study" 50 : 73-76, 1988

5 Fisch M, "Treatment of depression in cancer" 32 : 105-111, 2004

6 Walsh D, "The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients" 8 : 175-179, 2000

7 Sternbach H, "The serotonin syndrome" 148 : 705-713, 1991

8 Feighner JP, "The role of venlafaxine in rational adntidepressant therapy" 55 (55): 62-68, 1994

9 Goetz MP, "The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen" 101 : 113-121, 2007

10 Razavi D, "The effect of fluoxetine on anxiety and depression symptoms in cancer patients" 94 : 205-210, 1996

11 Portenoy RK, "Symptom prevalence, characteristic and distress in a cancer population" 3 : 183-189, 1994

12 Walsh D, "Symptom control in advanced cancer: important drugs and routes of administration" 27 : 69-83, 2000

13 Rodin G, "Supportive care guideline group of cancer care ontario program in evidence-based care. The treatment of depression in cancer patients: a systematic review" 15 : 123-136, 2007

14 Satel SL, "Stimulants in the treatment of depression: a critical overview" 50 : 241-249, 1989

15 Roth AJ, "Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer" 7 : 129-132, 1998

16 Torta R, "Sertraline effectiveness and safety in depressed oncological patients" 16 : 83-91, 2008

17 Alfano CM, "Recovery issues in cancer survivorship: a new challenge for supportive care" 12 : 432-443, 2006

18 Olin J, "Psychostimulants for depression in hospitalized cancer patients" 37 : 57-62, 1996

19 Kornblith AB, "Psychosocial adaptation of cancer survivors in Psycho-oncology" Oxford University Press 223-254, 1998

20 Massie MJ, "Prevalence of depression in patients with cancer" 32 : 57-71, 2004

21 van Heeringen K, "Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin" 169 : 440-443, 1996

22 Goodnick PJ, "Pharmacokinetic optimisation of therapy with newer antidepressants" 27 : 307-330, 1994

23 Pae CU, "Paroxetine in the treatment of depressed patients with haematological malignancy" 19 : 25-29, 2004

24 Musselman DL, "Paroxetine for the prevention of depression induced by high-dose interferon alfa" 344 : 961-966, 2001

25 Thompson DS, "Mirtazapine for the treatment of depression and nausea in breast and gynecological oncology" 41 : 356-359, 2000

26 Macleod AD, "Methylphenidate in terminal depression" 16 : 193-198, 1998

27 Fernandez F, "Methylphenidate for depressive disorders in cancer patients. An alternative to standard antidepressants" 28 : 455-461, 1987

28 Homsi J, "Methylphenidate for depression in hospice practice: a case series" 17 : 393-398, 2000

29 Fisch MJ, "Fluoxetine versus placebo in advanced cancer outpatients: a doubleblinded trial of the Hoosier Oncology Group" 21 : 1937-1943, 2003

30 Stahl SM, "Essential psychopharmacology of depression and bipolar disorder" Cambridge University Press 2000

31 Costa D, "Efficacy and safety of mianserin in the treatment of depression of women with cancer" 320 : 85-92, 1985

32 Kim SW, "Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression" 62 : 75-83, 2008

33 Stockler MR, "Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial" 8 : 603-612, 2007

34 Roscoe JA, "Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy" 89 : 243-249, 2005

35 Morrow GR, "Differential effects of paroxetine on fatigue and depression: a randomized double-blind trial from the University of Rochester Cancer Centre Community Clinical Oncology Program" 21 : 4635-4641, 2003

36 Cohen-Cole SA, "Diagnostic assessment of depression in the medically ill in Psychiatric Care of the Medical Patient" Oxford University Press 53-70, 1993

37 Wells KB, "Detection of depressive disorder for patients receiving prepaid or fee-for-service care. Results from the Medical Outcomes Study" 262 : 3298-3302, 1989

38 Raison CL, "Depression in cancer: new developments regarding diagnosis and treatment" 54 : 283-294, 2003

39 Miller K, "Depression and anxiety" 12 : 388-397, 2006

40 Yirmiya R, "Cytokines, “depression due to a general medical condition”, and antidepressant drugs" 461 : 283-316, 1999

41 Watson M, "Coping with cancer: the Mini-Mac. ICPO. Beaune"

42 Preskorn SH, "Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism" 32 (32): 1-21, 1997

43 Flint AJ, "Choosing appropriate antidepressant therapy in the elderly. A risk-benefit assessment of available agents" 13 : 269-280, 1998

44 Cullum JL, "Bupropion sustained release treatment reduces fatigue in cancer patients" 49 : 139-144, 2004

45 Ashbury FD, "Antidepressant prescribing in community cancer care" 11 : 278-285, 2003

46 Theobald DE, "An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms" 23 : 442-447, 2002

47 Moss EL, "An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners" 15 : 259-267, 2006

48 Ersoy MA, "An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients" 28 : 113-120, 2008

49 Plouffe L Jr, "An open trial of sertraline for menopausal hot flashes: potential involvement of serotonin in vasomotor instability" 69 : 481-482, 1997

50 Theobald DE, "An open label pilot study of citalopram for depression and boredom in ambulatory cancer patients" 1 : 71-77, 2003

51 Lydiatt WM, "A randomized, placebo-controlled trial of citalopram for the prevention of major depression during treatment for head and neck cancer" 134 : 528-535, 2008

52 Holland JC, "A randomized clinical trial of alprazolam versus progressive muscule relaxation in cancer patients with anxiety and depessive symptoms" 9 : 1004-1011, 1991

53 Weitzner MA, "A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer" 23 : 337-345, 2002

54 Homsi J, "A phase II study of methylphenidate for depression in advanced cancer" 18 : 403-407, 2001

55 Musselman DL, "A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression" 67 : 288-296, 2006

56 Holland JC, "A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer" 7 : 291-300, 1998